Jenny Wai

1.1k total citations
18 papers, 778 citations indexed

About

Jenny Wai is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Jenny Wai has authored 18 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in Jenny Wai's work include HIV/AIDS drug development and treatment (7 papers), Click Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). Jenny Wai is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Click Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). Jenny Wai collaborates with scholars based in United States and Japan. Jenny Wai's co-authors include Wayne J. Thompson, M. Katharine Holloway, Dong-Mei Feng, Roger Freidinger, Rhonda B. Levin, Joseph P. Vacca, Thomas A. Halgren, Paula M.D. Fitzgerald, Bruce D. Dorsey and Victor M. Garsky and has published in prestigious journals such as Journal of the American Chemical Society, Nature Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Jenny Wai

18 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Wai United States 14 425 227 130 130 99 18 778
Michael F. Gardner United States 19 615 1.4× 174 0.8× 114 0.9× 96 0.7× 34 0.3× 37 1.3k
Corey Strickland United States 15 598 1.4× 184 0.8× 120 0.9× 132 1.0× 222 2.2× 34 1.1k
Hadar Benyamini Israel 19 997 2.3× 157 0.7× 102 0.8× 55 0.4× 78 0.8× 40 1.4k
Clarissa G. Jakob United States 17 594 1.4× 119 0.5× 158 1.2× 74 0.6× 91 0.9× 23 1.0k
Lu Min Wong United States 15 477 1.1× 229 1.0× 276 2.1× 42 0.3× 37 0.4× 21 1.0k
Stanley D. Chamberlain United States 19 429 1.0× 476 2.1× 158 1.2× 177 1.4× 22 0.2× 35 1.0k
Edgar Specker Germany 16 405 1.0× 90 0.4× 98 0.8× 28 0.2× 63 0.6× 36 781
Todd W. Rockway United States 20 387 0.9× 237 1.0× 159 1.2× 126 1.0× 67 0.7× 38 940
Gianpaolo Fogliatto Italy 7 518 1.2× 100 0.4× 128 1.0× 31 0.2× 121 1.2× 9 761
Ernest J. McEachern Canada 17 872 2.1× 824 3.6× 122 0.9× 27 0.2× 39 0.4× 25 1.4k

Countries citing papers authored by Jenny Wai

Since Specialization
Citations

This map shows the geographic impact of Jenny Wai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Wai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Wai more than expected).

Fields of papers citing papers by Jenny Wai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Wai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Wai. The network helps show where Jenny Wai may publish in the future.

Co-authorship network of co-authors of Jenny Wai

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Wai. A scholar is included among the top collaborators of Jenny Wai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Wai. Jenny Wai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stachel, Shawn J., Melissa S. Egbertson, Jenny Wai, et al.. (2018). Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple species. Bioorganic & Medicinal Chemistry Letters. 28(6). 1122–1126. 3 indexed citations
2.
DuHadaway, James B., Khoa Pham, Ariel Lewis-Ballester, et al.. (2018). Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase. European Journal of Medicinal Chemistry. 162. 455–464. 42 indexed citations
3.
Malachowski, William P., James B. DuHadaway, Ariel Lewis-Ballester, et al.. (2015). O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1. European Journal of Medicinal Chemistry. 108. 564–576. 33 indexed citations
4.
Kuduk, Scott D., Ronald K. Chang, Jenny Wai, et al.. (2009). Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3). Bioorganic & Medicinal Chemistry Letters. 19(15). 4059–4063. 45 indexed citations
5.
Feng, Dong-Mei, Robert M. DiPardo, Jenny Wai, et al.. (2007). A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity. Bioorganic & Medicinal Chemistry Letters. 18(2). 682–687. 15 indexed citations
6.
Feng, Dong-Mei, Jenny Wai, Scott D. Kuduk, et al.. (2005). 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(9). 2385–2388. 23 indexed citations
7.
Kuduk, Scott D., Christina Ng, Dong-Mei Feng, et al.. (2004). 2,3-Diaminopyridine Bradykinin B1 Receptor Antagonists. Journal of Medicinal Chemistry. 47(26). 6439–6442. 34 indexed citations
8.
Brady, Stephen F., Joseph Pawluczyk, Patricia K. Lumma, et al.. (2002). Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity. Journal of Medicinal Chemistry. 45(21). 4706–4715. 43 indexed citations
9.
Defeo-Jones, Deborah, Stephen F. Brady, Dong-Mei Feng, et al.. (2002). A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.. PubMed. 1(7). 451–9. 33 indexed citations
10.
Garsky, Victor M., Patricia K. Lumma, Dong-Mei Feng, et al.. (2001). The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy. Journal of Medicinal Chemistry. 44(24). 4216–4224. 70 indexed citations
11.
Defeo-Jones, Deborah, Victor M. Garsky, Bradley K. Wong, et al.. (2000). A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo. Nature Medicine. 6(11). 1248–1252. 127 indexed citations
12.
Holloway, M. Katharine, Jenny Wai, Thomas A. Halgren, et al.. (1995). A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. Journal of Medicinal Chemistry. 38(2). 305–317. 178 indexed citations
13.
Vacca, Joseph P., Paula M.D. Fitzgerald, Paul L. Darke, et al.. (1994). Novel conformationally constrained HIV-1 protease inhibitors: rational design, enzyme inhibition, and X-ray structure of an enzyme-inhibtor complex. Bioorganic & Medicinal Chemistry Letters. 4(18). 2199–2204. 3 indexed citations
14.
Ghosh, Arun K., Wayne J. Thompson, M. K. HOLLOWAY, et al.. (1993). Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands. Journal of Medicinal Chemistry. 36(16). 2300–2310. 56 indexed citations
15.
Thompson, Wayne J., Arun K. Ghosh, M. Katharine Holloway, et al.. (1993). 3'-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease. Journal of the American Chemical Society. 115(2). 801–803. 31 indexed citations
16.
Ghosh, Arun K., Wayne J. Thompson, M. K. HOLLOWAY, et al.. (1993). ChemInform Abstract: Potent HIV Protease Inhibitors: The Development of Tetrahydrofuranylglycines as Novel P2‐Ligands and Pyrazine. Amides as P3‐Ligands.. ChemInform. 24(52). 2 indexed citations
17.
Tucker, Thomas J., William C. Lumma, Linda S. Payne, et al.. (1992). A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity. Journal of Medicinal Chemistry. 35(14). 2525–2533. 39 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael F. Gardner Breakdown of academic impact, for papers by Corey Strickland Breakdown of academic impact, for papers by Hadar Benyamini Breakdown of academic impact, for papers by Clarissa G. Jakob Breakdown of academic impact, for papers by Lu Min Wong Breakdown of academic impact, for papers by Stanley D. Chamberlain Breakdown of academic impact, for papers by Edgar Specker Breakdown of academic impact, for papers by Todd W. Rockway Breakdown of academic impact, for papers by Gianpaolo Fogliatto Breakdown of academic impact, for papers by Ernest J. McEachern
Rankless by CCL
2026